Latest News and Press Releases

New York, Oct. 31, 2019 (GLOBE NEWSWIRE) -- H.C. Wainwright has reiterated their “Buy” rating for Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of...

New York City, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, New York – News yesterday from...

New York City, NY, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Analysts for Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a patented diagnostic testing platform, maintained their...

New York City, New York, Aug. 29, 2019 (GLOBE NEWSWIRE) -- The Wall Street Analyzer recently completed and published an interview with the CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular...

New York City, New York, July 23, 2019 (GLOBE NEWSWIRE) -- News from Co-Diagnostics, Inc. (Nasdaq: CODX), a MedTech company with a patented platform for the development of molecular diagnostic...

New York City, July 08, 2019 (GLOBE NEWSWIRE) -- Respected ‘Silicon Review’ lists Co-Diagnostics in 50 Fastest Growing Companies of 2019 New York City, New York – The Silicon Review’s 50 Fastest...

New York City, June 26, 2019 (GLOBE NEWSWIRE) -- MedTech Outlook Names Co-Diagnostics Inc as Top 10 In-Vitro Diagnostic Provider for 2019 New York City, New York – MedTech Outlook’s 2019 Top 10...

New York, May 29, 2019 (GLOBE NEWSWIRE) -- CODX Reports Initial Domestic Sales Following Release of Q1 Numbers New York City, New York – Molecular diagnostics company Co-Diagnostics (Nasdaq: CODX)...

New York City, May 13, 2019 (GLOBE NEWSWIRE) -- H.C. Wainwright and Maxim Group Estimate Nearly 95% Upside for CODX New York City, New York – Analysts from H.C. Wainwright and Maxim Group have both...

New York City, May 13, 2019 (GLOBE NEWSWIRE) -- CEO Today Magazine Features Exclusive Interview with Co-Diagnostics Inc CEO Dwight Egan New York City, New York – The May 2019 issue of the...